ENTITY
Pixium Vision Sa

Pixium Vision Sa (PIX FP)

37
Analysis
Health CareFrance
Pixium Vision SA develops retinal implant systems. The Company develops epi-retinal and sub-retinal implant systems to treat patients who have lost their sight, with the intention of improving their vision and enabling them to lead more independent lives. Pixium Vision markets its systems throughout Europe.
more
Refresh
08 Jun 2021 21:40Issuer-paid

Pixium Vision - Signalling an intent to access US investors

Pixium provided a minor business update on 2 June, indicating that it is seeking to capitalise on increased interest from US investors in recent...

Share
29 Oct 2020 22:14Issuer-paid

Pixium Vision - Q3 results in line, awaiting pivotal study approval

Pixium Vision provided an update on its 9M20 cash flow results, which are broadly in line with H120 trends. The company reported a 9M20 operating...

Share
28 Jul 2020 22:56Issuer-paid

Pixium Vision - H120 results broadly in line

Pixium Vision recently reported H120 results that were broadly in line with our forecasts. The operating loss of €3.27m was mildly above our €2.77m...

Share
09 Jul 2020 15:24Issuer-paid

Pixium Vision - €7.3m capital increase completed

Pixium on 6 July reported that it has raised €7.3m through its shareholder rights offering initiative. The subscription rate was >94% and 14.68m...

Share
22 Jun 2020 14:48Issuer-paid

Pixium Vision - Restoring eyesight in advanced Dry-AMD

Pixium Vision is developing Prima 2, a potentially breakthrough wireless bionic vision system (BVS) that generates electrical impulses at the...

Share
x